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Childhood wheezing phenotypes and 
FeNO in atopic children at age 8
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Abstract
Background
Fractional exhaled Nitric Oxide (FeNO) is a surrogate biomarker of the degree of eosinophilic 
airway inflammation. Using longitudinal latent class analysis, five wheezing phenotypes have 
been identified, characterized by different ages of onset and prognosis.
Objectives
To assess FeNO measured at 4 and 8 years in children with different phenotypes of wheeze and 
atopy.
Methods
Children participated in the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) 
study, a prospective birth cohort in the Netherlands. Respiratory health was assessed yearly by 
questionnaires until the age of 8 years; these data were used to identify five wheezing phenotypes. 
Associations between FeNO and wheezing phenotypes were investigated using weighted linear 
regression.
Results
Data on wheezing phenotypes and FeNO at 4 and 8 years were available in 588 and 973 children 
respectively. Compared with the phenotype of never and transient wheeze, FeNO at 4 years was 
higher in intermediate onset and persistent wheeze. FeNO at 8 years of age differed significantly 
between all phenotypes, with highest FeNO values for persistent, intermediate onset, and late 
onset wheeze. Rise in FeNO from 4 to 8 years in intermediate and late onset wheezers was 
significantly higher compared to FeNO rise in never and transient wheezers. Stratified analyses 
showed that the increase in FeNO in persistent, intermediate, and late onset wheeze was only 
present in children with allergic sensitization at 8 years.
Conclusions and Clinical Relevance
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Introduction
The fraction of nitric oxide in exhaled air (FeNO) is a non-invasive surrogate biomarker of the 
degree of eosinophilic airway inflammation with excellent reproducibility in childhood.1,2 Recent 
studies have shown that FeNO can be used both in large population-based studies and in clinical 
asthma management studies.3,4 Elevated FeNO was found in children and adults with asthma and 
atopy,2,3,5,6 overlapping with the distribution in normals.7.8 We previously reported on FeNO in 
4-year-old children from the The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) 
cohort, and found no association with classic wheezing phenotypes as described by Martinez 
in preschool children.8,9 However, FeNO may be influenced by atopy, which can develop later 
in life.2,10-12 PIAMA birth cohort study provided the opportunity to study FeNO in relation to 
phenotypes of wheeze in a large group of children recruited from the general population. One of 
the special features of PIAMA is the yearly respiratory health assessment, which can be used to 
define phenotypes of wheeze. Recently, phenotypes of wheeze were identified by Longitudinal 
Latent Class Analysis (LLCA) in the Avon Longitudinal Study of Parents and Children (ALSPAC) 
study, and these phenotypes were differently associated with atopy and lung function.13 This 
analysis was repeated in the PIAMA study and resulted in comparable phenotypes with similar 
associations with doctor-diagnosed asthma, inhaled corticosteroid use, sensitization to common 
allergens, forced expiratory volume in1 second, and bronchial responsiveness.14 FeNO has not 
been studied in relation to phenotypes identified using this novel approach. We hypothesized that 
the different wheezing phenotypes are characterized by differences in eosinophilic inflammation, 
which would be reflected by differences and change in FeNO measured at the age of 4 and 8 
years. Because atopy is an important determinant of FeNO, we stratified our analysis for atopy.2
Materials and methods
Study design
The Prevention and Incidence of Asthma and Mite Allergy study is a prospective birth cohort 
study in the Netherlands. Recruitment took place in 1996–97 through prenatal clinics; 7862 
pregnant women were invited to participate, 4146 (53%) agreed and gave informed consent. 
Children were labelled as high risk (n = 1327) and low risk (n = 2819), based on the atopic status 
of the mother. Respiratory health and asthma symptoms of the children were assessed yearly by 
questionnaires, partly based on the International Study of Asthma and Allergies in Childhood 
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risk factors.15 All high-risk children and a subgroup of low-risk children were invited for FeNO 
measurement at the age of 4 years (n = 1808) and 8 years (n = 1554). A detailed description 
of the PIAMA study design was previously published.8,16 The study protocol was approved by 
the medical ethics committees of the participating medical centres (Groningen: M 4.019912, 
Rotterdam: MEC 2004-152, and Utrecht: CCMO P04.0071C 04-101/K).
Study population
At the age of 4 years all high-risk (n = 1173) and a random sample of low-risk children 
(n = 635) were invited for a medical examination, including offline FeNO measurement. Of those 
1808 children 1269 attended the examination, and an exhaled air sample was obtained in 939 
children. Offline FeNO measurements of sufficient quality were obtained in 595 children (63%) 
at age 4.8 At 8 years also all high-risk children still in follow-up (n = 988) and a similar, random 
sample of low-risk children (n = 566) were invited for a hospital-based medical examination 
including online FeNO measurement. Of these 1554 children 1129 (73%) gave informed consent 
and attended the examination. In 39 children a FeNO measurement could not be performed due 
to device failure. Of the remaining 1090 children at least one successful FeNO measurement was 
obtained in 976 children (90%). The other 114 children were unable to exhale at a constant flow 
during FeNO measurement. A detailed flow chart of the study population with complete data 
on confounders, wheezing phenotypes, and FeNO at 4 years (n = 588) and 8 years (n = 973) is 
presented in Figure 1.
Measurements
The FeNO in 4-year-old children was measured offline by the balloon method,17 according to 
European Respiratory Society (ERS)/American Thoracic Society guidelines (ATS).8,18 FeNO in 8-year-
old children was measured online using the NIOX chemiluminescence analyser (Aerocrine AB, 
Solna, Sweden) according to ERS and ATS guidelines.1 We previously found good agreement 
between these online and offline FeNO measurements.19 At 8 years blood was drawn to assess 
sensitization to airborne allergens, defined as specific IgE of 0.70 IU/mL for at least one of the 
following allergens: house dust mite (Dermatophagoides pteronyssinus), cats, dogs, grass pollen 
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Screenings questionnaire in pregnant women (n=10,232)
Invited pregnant women (n=7862)
Agreed with informed consent (n=4146*)
Children in study after birth (n=3963)
n=3963
âFENO at 4 years n=3963 âFENO at 8 years n=3963
Invited for FENO at 4 years (n=1808) Invited for FENO at 8 years (n=1554)
No consent (n=539) No consent (n=425)
Informed consent measurement (n=1269) Informed consent measurement (n=1129)
No attempt 
(n=330)
NO analyser not available
No attempt
(n=39)
device failure NO analyzer
FENO measurement attempted (n=939) FENO measurement attempted (n=1090)
Not successful (n=344) due 
to fear, reluctance, inability, 
technical problems
Not successful (n=114) due to 
inability to breath at constant 
flow
FENO measurement successful 
(n=595; success rate 63%)
FENO measurement successful 
(n=976; success rate 90%)
Data on wheezing phenotype 
not complete (n=133)
Data on wheezing phenotype 
not complete (n=173)
Complete data on FeNO at 4 years and 
wheezing phenotypes (n=462)
Complete data on FeNO at 8 years and 
wheezing phenotypes (n=803)
Included in analysis at 4 years (n=462) Included in analysis at 8 years (n=803)
Figure 1. Flow chart of study population at 4 and 8 years.
*: These 4146 consisted of 1327 atopic (32%) and 2819 non-atopic mothers (68%), which is a good 
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Phenotypes of wheeze
Longitudinal latent class analysis was used by Savenije et al. to define wheezing phenotypes in 
PIAMA in early childhood, as originally published by Henderson et al.13 Wheezing phenotypes 
were previously defined in children with at least data on wheezing at two or more occasions, 
and in a subgroup of children with complete data on wheezing at every age from 1 to 8 years.14 
There were no major differences between these two analyses. In the current analysis phenotypes 
derived in children with at least two wheezing observations were used, to minimize the risk 
of selection bias. Five wheezing phenotypes were identified in the first 8 years of life: never/
infrequent wheeze (73.2%), transient early wheeze (17.3%), intermediate onset wheeze (3.4%), 
persistent wheeze (4.3%), and late onset wheeze (1.8%). These phenotypes were comparable 
with those identified in the ALSPAC cohort.14 The five phenotypes are graphically depicted in 
Figure 2.
Figure 2. Probability of wheeze at each time point from birth to age 8 years for each wheezing phenotype in 
the prevention and incidence of asthma and mite allergy (N = 3,789).
The prevalences of the phenotypes are shown next to the phenotypes in the legend. Figure adjusted from 
Savenije & Granell et al., with copyright permission.14
Statistical analysis
All analyses were carried out in SAS 9.1 (SAS Institute, Inc., Cary, NC, USA). The associations 
between FeNO at 4 and 8 years and phenotypes of wheeze were investigated with weighted 
linear regression models (SAS PROC GENMOD). FeNO data were log-transformed, to achieve a 
normal distribution for linear regression analyses and back-transformations were used to calculate 
geometric mean FeNO for the phenotypes of wheeze. Due to the stratified study design, all 
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children separately. The analyses were also stratified for allergic sensitization at 8 years, because 
specific IgE is an important determinant of FeNO.2 Individual membership probabilities (each child 
gets a probability to belong to each phenotype) derived from LLCA were used as weight factors in 
the linear regression models to minimize the risk of misclassification of the wheezing phenotypes. 
Gender, recent symptoms of cold, steroid use, study region, education of the mother, and exposure 
to environmental tobacco smoke were considered as potential confounders. Confounders were 
included in the models based on their association with wheezing phenotypes, or if they changed 
the effect estimate by more than 10%.
Results
General characteristics of the study population
Baseline characteristics at 4 and 8 years are given in Table I. Due to the study design, high-risk 
children were overrepresented in comparison with the total PIAMA population. Compared to 
those invited for medical examination at 8 years (n = 1554), children with complete FeNO data 
at 8 years had a higher level of maternal education and lower prevalence of prenatal smoking. 
However, differences were small, and with respect to other general characteristics the groups 
were similar (Table I). Among children with complete FeNO data at the age of 4 years, there was 
an overrepresentation of the Western study region and an underrepresentation of the Northern 
and Middle study regions due to technical problems with FeNO measurements. This may explain 
the somewhat lower proportion of never/infrequent wheeze and late onset wheeze compared to 
the population invited for medical examination.
Associations of FeNO values at 4 years and phenotypes of wheeze
Phenotypes of wheeze were derived from yearly respiratory health assessments from birth up 
to 8 years. The adjusted geometric mean FeNO was highest in intermediate onset wheeze and 
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Table I. General characteristics of study population.
Invited for 








FeNO data at 8 yrs 
(n=973)
Gender (% females) 49 48 50
Study region
West 31 50 32
Middle 37 34 38
North 32 16 29
Maternal education level
Low 22 21 20
Middle 42 41 42
High 36 38 38
Caesarean section 9 8 10
Atopic mother* 64 66 66
Atopic father* 32 32 32
Exposure to pets in 1st yr 48 47 47
Older siblings (% present) 48 49 47
Daycare attendance in 1st yr 24 28 25
Smoking during pregnancy 16 14 15
Exposure to environmental tobacco smoke† 16 15 16
Inhaled steroid use† 9 9 9
Doctors’ diagnosis asthma† 12 14 12
Phenotypes of wheeze‡
Never/infrequent wheeze 69.9 66.5 68.8
Transient early wheeze 18.6 21.8 19.7
Intermediate onset wheeze 3.9 4.4 4.0
Persistent wheeze 5.1 5.7 5.2
Late onset wheeze 2.5 1.6 2.2
Specific IgE inhalant allergen age 8
Positive for at least 1 of the 6 tested allergens¶ 30 30 29
Values are percentages (%). *: Defined as a positive report of hayfever, allergy and/or asthma. †: Reported 
at the age of 8 years. ‡: Defined using longitudinal latent class analysis as previously described 14, known in 
1165/1554 children invited at 8 years. ¶: The following 6 inhalant allergens were tested for: house dust mite 
(Dermatophagoides pteronyssinus), cats, dogs, grass pollen (Dactylis glomerata), birch, Alternaria alternata. 
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Table II. Adjusted geometric mean FeNO (ppb) and change in FeNO per phenotype of wheeze at 4 and 8 
years.
FeNO at 4 years
(N=588)
FeNO at 8 years
(N=973)
Difference in FeNO


























































Analyses were weighted for the probability that a child belongs to a certain phenotype (individual posterior 
membership probabilities). *: Frequency (n) of each wheezing phenotype is calculated as the sum of the 
membership probability of all children for that phenotype. †: Geometric mean FeNO value (95% confidence 
interval) in ppb per phenotype of wheeze, adjusted for gender, recent symptoms of cold, study region and 
education of the mother. ‡: p<0.05 for difference in comparison with never/infrequent wheeze. ¶: p<0.05 
for difference in comparison with transient wheeze. #: At 8 years FeNO in every phenotype was significantly 
(p<0.01) different in comparison to all other phenotypes.
Associations of FeNO values at 8 years among different phenotypes of wheeze
The FeNO at 8 years of age differed significantly among all phenotypes. It should be noted that 
also at 8 years of age, there was considerable overlap in FeNO among all phenotypes. FeNO was 
highest when wheeze started later in life and persisted longer, in intermediate onset wheeze, 
persistent wheeze, and late onset wheeze. The adjusted geometric mean FeNO for each wheezing 
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 

Figure 3. Box plots of FeNO at 8 years per phenotype of wheeze.
Horizontal lines indicate the median Fractional exhaled Nitric Oxide. Upper/lower limits of the box, outer 
lines and dots represent the 25th/75th, the 10th/90th, and the 5th/95th percentiles respectively. Data were 
weighted for the probability that a child belongs to a certain phenotype (individual posterior membership 
probabilities).
Change in FeNO over time was analysed in the subgroup of children with FeNO measurements 
both at 4 and 8 years. FeNO in intermediate and late onset wheezers was significantly higher 
compared to never/ infrequent and transient wheezers.
Environmental tobacco smoke and steroid use did not change the association between FeNO and 
phenotype of wheeze. These variables add up to 6.5% missing data and were not included in the 
final model to increase power. None of the other potential confounders changed the association 
by 10%. Steroids were mainly used in intermediate-, late onset- and persistent wheeze, and this 
might lead to underestimation of the differences between these phenotypes and the reference 
group. We think that this is not the case because exclusion of children using steroids at 8 years led 
to similar results of the phenotypes. To investigate whether the association between FeNO and 
the wheezing phenotypes may be caused solely by the association between FeNO and wheeze 
at the age that FeNO was measured, we performed sensitivity analyses adjusting for current 
wheeze at the ages of 4 and 8 years (ISAAC question: reported wheezing symptoms in the past 
year). This adjustment did not alter the associations between FeNO and phenotypes of wheeze. 
All analyses were repeated using wheezing phenotypes defined in the subgroup of children with 
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FeNO values and phenotypes of wheeze in atopic and non-atopic children
We performed stratified analyses based on atopy of the mother. The associations between FeNO 
and phenotypes were similar. However, we found a strong and significant interaction with allergic 
sensitization of the children themselves at the age of 8 years (overall P-value for interaction 
<0.001). Among children with elevated specific IgE, FeNO levels at 8 years were low in never/
infrequent wheeze and transient early wheeze, and significantly elevated in the remaining 
persistent phenotypes. In children without elevated specific IgE for inhalant allergens, FeNO levels 
at 8 years were not significantly associated with phenotypes of wheeze. Because the numbers of 
children with low specific IgE were small for the wheezing phenotypes with persistent symptoms 
[intermediate onset wheeze (n = 10), persistent wheeze (n = 20), and late onset wheeze 
(n = 5)], these phenotypes were also combined for this analysis. Table III shows that, among atopic 
children, all three phenotypes with persistent symptoms had a significantly higher FeNO level 
than never/infrequent and transient wheeze, while no such association was present in non-atopic 
children. This interaction is illustrated in Figure 4.








n* mean (95% CI) † n*
mean 
(95% CI) †
Never/infrequent 23.9 410 7.9 (7.5;8.4) 129 13.5 (12.0;15.3)
Transient early 27.3 117 7.3 (6.5;8.3) 44 11.8 (9.1;15.2)‡
Intermediate onset 67.7 10 9.0 (7.1;11.4) 21 22.6 (16.7;30.6)‡
Persistent 51.2 20 8.2 (6.8;9.8) 21 20.9 (15.4;28.3)‡
Late onset 72.2 5 8.2 (6.0;11.3) 13 29.4 (20.7;41.8)‡
Combined persistent 
phenotypes¶
61.1 35 8.4 (7.2;9.8) 55 22.8 (17.8;29.2)‡
We found significant interaction between phenotypes of wheeze and allergic sensitization on FeNO levels 
(p-interaction < .001). Atopy of the child defined as specific IgE of ≥ 0.70 IU/mL for at least one inhalant 
allergen at the age of 8 years. Analyses were weighted for the probability that a child belongs to a certain 
phenotype (individual posterior membership probabilities). *: Frequency (n) of each wheezing phenotype is 
calculated as the sum of the membership probability of all children for that phenotype. †: Geometric mean 
FeNO value (95% confidence interval) (ppb) per phenotype of wheeze stratified for atopy at 8 years, adjusted 
for gender, recent symptoms of cold, study region and education of the mother. ‡: p<0.05 for difference in 
comparison with never/infrequent wheeze. ¶: Due to the smaller sample size, 3 phenotypes with persistent 
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

Figure 4. Boxplots of FeNO at 8 years per phenotype of wheeze, stratified for atopy.
Atopy of the child defined as a specific IgE of ≥0.70 IU/mL for at least one of the tested inhalant allergens 
at the age of 8 years. Horizontal lines indicate the median fractional exhaled nitric oxide. Upper/lower 
limits of the box, outer lines and dots represent the 25th/75th, the 10th/90th, and the 5th/95th percentiles 
respectively. Data were weighted for the probability that a child belongs to a certain phenotype (individual 
posterior membership probabilities).
Discussion
We examined FeNO at 4 and 8 years in relation to phenotypes of wheeze and atopy. We found 
that FeNO at 4 years was higher in intermediate onset and persistent wheeze compared to never 
and transient wheeze. The association between phenotypes of wheeze and FeNO measured at 
8 years was much stronger. FeNO at 8 years was significantly higher in persistent phenotypes of 
wheeze (including intermediate onset, persistent, and late onset wheeze) compared to never 
and transient wheeze, but only among children with allergic sensitization at 8 years. Smaller but 
significant differences were observed for FeNO at 8 years among the three persistent phenotypes.
FeNO and wheezing phenotypes
Previous studies have reported increased FeNO in asthmatic children,3,520-22 while others did not 
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phenotypes that may or may not share the same inflammatory mechanisms.9,13,14,25 Lumping all 
these phenotypes together as a single disease entity might hamper our efforts to understand 
the aetiology and pathophysiology of specific phenotypes.25,26 The presence of such differences 
has been suggested in studies that assessed airway inflammation using bronchoalveolar lavage 
(BAL).27 BAL is an invasive procedure and hence not feasible for research purposes in children 
with mild disease. Only few studies investigated the association between non-invasive surrogate 
markers of airway inflammation, like FeNO, and wheezing phenotypes in early childhood. Moeller 
et al. measured higher FeNO levels in wheezing preschool children compared to non-wheezers, in 
line with our findings. Among wheezing children the authors found higher FeNO levels in children 
with a positive asthma prediction index, which is suggestive of persistent symptoms.28 In contrast, 
we found no differences in FeNO at the age of 4 between transient and late onset wheezers. This 
may be explained by differences in classification using the asthma predictive index or longitudinal 
latent class analysis. Brussee et al. found in the PIAMA study only a weak association of FeNO at 
4 years with phenotypes of wheeze up to that age, with slightly higher FeNO levels in children 
who wheezed at the age of 4 years, compared to those who never wheezed.8 Also in the 
present study only weak associations between phenotype and FeNO at 4 years were found. This 
could be explained by an increase in chronic airway inflammation with age,29 with differences 
in FeNO becoming detectable only after the age of 4 years. However, the early development 
of eosinophilic inflammation as an underlying mechanism of persistent wheeze is not well 
understood. Alternatively, differences in the methods of FeNO measurement at 4 and 8 years 
might be involved, but we earlier found that these online and offline methods give similar results, 
so this seems unlikely.19 At 8 years, FeNO levels were increased in the phenotypes with persistent 
symptoms compared to never and transient wheezers. Differences in FeNO at 8 years between 
the three persistent phenotypes (intermediate onset, persistent, and late onset wheeze) were 
not only smaller, but also significant. These results need to be interpreted with some caution, as 
significant differences may have resulted from multiple testing. We analysed change in FeNO over 
time. Despite the small numbers, the rise in FeNO in intermediate onset and late onset wheezers 
was significantly higher compared to that in never/infrequent and transient wheezers. Possibly 
the underlying disease process in late onset wheezers leads to a faster increase of eosinophilic 
inflammation between 4 and 8 years. Elevated FeNO levels were especially pronounced in the 
phenotypes with onset of wheezing after the age of 2 years.
FeNO and atopy
We found a strong association between atopy and FeNO. This is a consistent finding in earlier 
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be entirely explained by atopy, implying that measuring FeNO is of limited use to assess whether 
or not a child has asthma.30 The present study showed that FeNO is not simply a marker of atopy, 
but that the presence of atopy modifies the association between wheezing phenotypes and 
FeNO, which is in line with previous studies.6,23 Indeed, FeNO levels differed substantially between 
the wheezing phenotypes in atopic children at 8 years. Furthermore, this shows that not only all 
wheezing phenotypes occur in atopic and non-atopic children, but that the pathophysiology of 
wheeze in these two groups is probably different. As FeNO has been shown to correlate with 
eosinophilic airway inflammation, we speculate that a predominant eosinophilic inflammation 
might be present selectively in atopic children with persistent phenotypes of wheeze. Other 
mechanisms may play a role in the pathophysiology of transient wheeze and of persistent wheeze 
in non-atopic children. Possible mechanisms include smaller airway calibre and/or neutrophilic 
airway inflammation.27
Strengths and limitations
A strong point of our study is that we assessed wheezing prospectively and that the wheezing 
phenotypes were discovered without pre-specified constraints in two large birth cohorts, 
using longitudinal latent class analysis.13,14 Well-standardized FeNO measurements,1 objective 
assessment of atopy at 8 years, and the large size of the PIAMA cohort with good followup 
allowed us to detect significant differences in FeNO in less common phenotypes, even after 
stratification for atopy.
A point of consideration in the interpretation of the data is that some children were using inhaled 
steroids while FeNO was measured, and it has been shown that steroids can decrease FeNO.2 
However, any such effect seems limited because a sensitivity analysis after exclusion of steroid 
users did not change the results. In addition, one should take into account the possibility that the 
reported association between FeNO and phenotypes of wheeze solely depends on the relation 
between FeNO and current wheeze at the age of 8 years. This seems unlikely, because adjustment 
for current wheeze at 8 years did not alter any of the associations between FeNO and phenotypes 
of wheeze. The present study used parent-reported wheezing symptoms. This method of 
assessing symptoms is widely accepted in epidemiological asthma studies,31 but may lead to 
misclassification. Because parents were unaware of their child’s FeNO level, any misclassification 
of wheezing would be independent of FeNO, resulting in a diluting effect with underestimation of 
the true differences in FeNO between the wheezing phenotypes. Furthermore, the small sample 
sizes at the age of 4 years should be noted, which may have decreased the power to detect 
significant associations between FeNO and the less frequent wheezing phenotypes. This holds 
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among the non-atopic children. FeNO was not measured in early life and our data can therefore 
not confirm earlier findings that FeNO might be increased in transient early wheeze at a time 
when wheeze was still present.32
Conclusion
The FeNO measured at 8 years differed among wheezing phenotypes, only in atopic children. 
Hence, we speculate that the pathophysiology of wheezing phenotypes differs between atopic 
and non-atopic children. Whether or not eosinophilic inflammation is indeed causally involved in 
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